Dr. Ayaz Mahmood Khan

Pain Management • Williamsport, PA

Home/Williamsport/Pain Management/Dr. Ayaz Mahmood Khan

About

Pain Management of Williamsport, LLC is a private healthcare provider focused on chronic pain and addiction treatment. Based in Williamsport, PA, they operate since 2004 with three offices (all listed at 553 E 3rd St, Williamsport, PA 17701). Key details: - Industry: Hospitals and Health Care; specialties include chronic pain management and addiction treatment - Contact: 570-323-3106 - Locations: 3 offices in the United States (all in Williamsport, PA)

Call clinic Visit website

Clinic Type

Pain Management

Address

553 E 3RD ST, WILLIAMSPORT, Pennsylvania 17701, US

Phone

570-323-3106

Email

—

Opening Hours

Mon-Fri 8:30 am - 5:30 pm

Website

https://www.painmanagementandaddictiontreatment.com/

Services Offered

—

Team

Dr. Ayaz Mahmood Khan — Physician/Medical Director

Insurance & Payment

—

Languages Spoken

—

Social Media

Tiktok Facebook Linkedin Instagram

Photos

What Patients Say

Overall sentiment across review platforms: mixed

WebMD: 4.5/5 (WebMD) (42)
PainClinics.com: 4.7/5 (104)
uscompanies.net: Low rating overall (based on 5 user reviews listed on source) (5)

Patients praise

personable and caring doctor
effective pain management results for some patients
polite and professional office manager (Laura)
clear communication of medical conditions

Common complaints

long wait times for appointments
concerns that pain issues were not addressed or taken seriously
reports of being dropped as a patient following negative reviews

"Dr. Khan and Laura are absolutely amazing! I wish he was my family doctor. He treats his patients as family and goes above and beyond to listen, and help his patients."

— Nancy Brooks (Testimonial on Practice Website)

"Almost every time I go I have to wait about an hour and a half padt my appointment time to be seen. ... I was dropped as a patient today due to an honest review of my experience."

— Anonymous Patient (uscompanies.net)

Synthesized from public review platforms as of Jul 11, 2026 — sources: [1][2][3][4].